A detailed history of Accent Capital Management, LLC transactions in Novo Cure LTD stock. As of the latest transaction made, Accent Capital Management, LLC holds 96 shares of NVCR stock, worth $1,640. This represents 0.0% of its overall portfolio holdings.

Number of Shares
96
Previous 143 32.87%
Holding current value
$1,640
Previous $2.45 Million 38.78%
% of portfolio
0.0%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$15.61 - $23.34 $733 - $1,096
-47 Reduced 32.87%
96 $1.5 Million
Q2 2024

Aug 12, 2024

BUY
$11.83 - $24.05 $295 - $601
25 Added 21.19%
143 $2.45 Million
Q4 2023

Mar 19, 2024

BUY
$11.13 - $15.78 $1,313 - $1,862
118 New
118 $1.76 Million

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.79B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Accent Capital Management, LLC Portfolio

Follow Accent Capital Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accent Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Accent Capital Management, LLC with notifications on news.